WELL Health Technologies (TSE:WELL) Price Target Lowered to C$7.60 at Ventum Financial

WELL Health Technologies (TSE:WELL - Get Free Report) had its target price lowered by equities research analysts at Ventum Financial from C$8.00 to C$7.60 in a report released on Wednesday,BayStreet.CA reports. The firm currently has a "buy" rating on the stock. Ventum Financial's target price would suggest a potential upside of 101.59% from the stock's current price.

A number of other research analysts also recently weighed in on WELL. Raymond James increased their target price on shares of WELL Health Technologies from C$10.00 to C$11.00 in a research report on Tuesday, December 17th. Royal Bank of Canada dropped their price target on WELL Health Technologies from C$8.50 to C$7.50 and set an "outperform" rating on the stock in a research report on Monday, March 31st. Finally, TD Securities dropped their price objective on shares of WELL Health Technologies from C$8.50 to C$7.50 and set a "buy" rating on the stock in a report on Wednesday, April 16th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, WELL Health Technologies has a consensus rating of "Moderate Buy" and a consensus target price of C$8.08.

WELL Health Technologies Stock Performance

TSE:WELL traded down C$0.19 during trading on Wednesday, reaching C$3.77. The company's stock had a trading volume of 1,110,064 shares, compared to its average volume of 1,005,995. WELL Health Technologies has a 12 month low of C$3.48 and a 12 month high of C$7.36. The firm has a market cap of C$942.21 million, a price-to-earnings ratio of 12.77, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20. The firm has a 50 day moving average of C$5.07 and a 200-day moving average of C$5.56. The company has a debt-to-equity ratio of 46.79, a quick ratio of 1.02 and a current ratio of 1.14.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.